Myofascial Release in Patients with Chronic Obstructive Pulmonary Disease
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Experimental-Myofascial + Respiratory rehabilitation, Sham Myofascial + Respiratory rehabilitation.
- Who it may be relevant to
- Registry conditions: Copd. Basic parameters: 18 years — 75 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Effects of Myofascial Release in Patients with Chronic Obstructive Pulmonary Disease: a Randomized Clinical Trial
Overview
The main objective of this study is to assess the effects of a myofascial release protocol in patients with chronic obstructive pulmonary disease (COPD).
Detailed description
So far, there are no previous studies that analyze the effects of a myofascial relaxation protocol applied to the diaphragm within the respiratory rehabilitation treatment in patients with chronic obstructive pulmonary disease.
Aim: The main objective of this study is to assess the effects of a 3 weeks myofascial release protocol applied to the diaphragm on respiratory parameters in patients with chronic obstructive pulmonary disease.
Design: Randomized clinical trial
Interventions
- Other Experimental-Myofascial + Respiratory rehabilitation
6 sessions of: Myofascial Release (20 minutes each) + Respiratory rehabilitation (60 minutes each) - Other Sham Myofascial + Respiratory rehabilitation
6 sessions of: Sham Myofascial Release (20 minutes each) + Respiratory rehabilitation (60 minutes each)
Primary outcome measures
- Quality of life measured with the Chronic Obstructive Pulmonary Disease Assessment Test: Score [Time frame: 3 weeks]
Secondary outcome measures (1)
- 6 Minutes Walking Test [Time frame: 3 weeks]
Eligibility criteria
Inclusion criteria
- COPD;
- Forced expiratory volume in the first second (FEV1) < 80%;
- FEV1/Forced vital capacity (FVC) < 70%;
- Maximal inspiratory pressure (MIP) < 70%.
Exclusion criteria
- Recent (6 months) spine or abdominal surgery;
- Allergic status of any kind;
- systemic diseases (rheumatic, infectious conditions, febrile state, vascular alterations, endocrine diseases including diabetes, metabolic, and neoplastic syndromes);
- neuromuscular or neurological injuries;
- previous myofascial release treatment.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Double blind
- Primary purpose
- Treatment
Study locations
Center list to be confirmed — check the primary protocol.
Publications
- Rocha T, Souza H, Brandao DC, Rattes C, Ribeiro L, Campos SL, Aliverti A, de Andrade AD. The Manual Diaphragm Release Technique improves diaphragmatic mobility, inspiratory capacity and exercise capacity in people with chronic obstructive pulmonary disease: a randomised trial. J Physiother. 2015 Oct;61(4):182-9. doi: 10.1016/j.jphys.2015.08.009. Epub 2015 Sep 19. PMID 26386894
- Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DM, Lopez Varela MV, Nishimura M, Roche N, Rodriguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agusti A. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary. Arch Bronc PMID 28274597
Identifiers
NCT: NCT04260243 · UNIVERSITY CARDENAL HERRERA-23